{"transactions":[{"id":777185,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":46920,"kind":"person","name":"Mano Michael","position":1,"cik":"0001837741","reported_name":"Mano Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CLO&Secretary"}}],"security":"Common Stock","published_at":"2026-05-15T20:02:41.000Z","date":"2026-05-14","kind":"sale","planned":false,"acquired":false,"shares":266,"price":9.5,"value":2527.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was effected pursuant to a durable automatic sale instruction plan adopted by the reporting person on May 16, 2022, and represents a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of PSUs. The sale does not represent a discretionary trade by the reporting person."}],"balance_after":94398,"source":{"system":"sec-edgar","filing":"0001193125-26-226604","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1837741/000119312526226604/ownership.xml","form_type":"4"}},{"id":777184,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":46920,"kind":"person","name":"Mano Michael","position":1,"cik":"0001837741","reported_name":"Mano Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CLO&Secretary"}}],"security":"Common Stock","published_at":"2026-05-15T20:02:41.000Z","date":"2026-05-13","kind":"grant","planned":false,"acquired":true,"shares":700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of the issuer's common stock underlying performance-based restricted stock units (\"PSUs\") granted in February 2024 that have been earned based on the level of achievement of the clinical milestone for complete enrollment in the Company's Phase 3 XPORT-EC-042 trial, as certified by the issuer's Compensation Committee on May 13, 2026. Each earned PSU represents the contingent right to receive one share of the issuer's common stock upon vesting. The earned PSUs vested on May 13, 2026."}],"balance_after":94664,"source":{"system":"sec-edgar","filing":"0001193125-26-226604","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1837741/000119312526226604/ownership.xml","form_type":"4"}},{"id":868036,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":46920,"kind":"person","name":"Mano Michael","position":1,"cik":"0001837741","reported_name":"Mano Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CLO&Secretary"}}],"security":"Common Stock","published_at":"2026-03-03T21:28:39.000Z","date":"2026-03-02","kind":"sale","planned":false,"acquired":false,"shares":3526,"price":9.4095,"value":33177.897,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a durable automatic sale instruction plan adopted by the reporting person on May 16, 2022, and represents a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of restricted stock units. The sale does not represent a discretionary trade by the reporting person."}],"balance_after":93964,"source":{"system":"sec-edgar","filing":"0001837741-26-000003","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1837741/000183774126000003/ownership.xml","form_type":"4"}},{"id":922108,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":46920,"kind":"person","name":"Mano Michael","position":1,"cik":"0001837741","reported_name":"Mano Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CLO&Secretary"}}],"security":"Common Stock","published_at":"2026-02-03T21:28:17.000Z","date":"2026-01-31","kind":"grant","planned":false,"acquired":true,"shares":32415,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the award of restricted stock units (\"RSUs\") pursuant to the Karyopharm Therapeutics Inc. 2022 Equity Incentive Plan, as amended. RSUs convert into Karyopharm Therapeutics Inc. common stock on a one-for-one basis. The RSUs vest as to 50% of the shares on January 31, 2027, with the remaining 50% vesting on January 31, 2028."}],"balance_after":97490,"source":{"system":"sec-edgar","filing":"0001193125-26-035661","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1837741/000119312526035661/ownership.xml","form_type":"4"}},{"id":1017645,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":46920,"kind":"person","name":"Mano Michael","position":1,"cik":"0001837741","reported_name":"Mano Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, General Counsel&Secretary"}}],"security":"Common Stock","published_at":"2025-10-16T20:30:58.000Z","date":"2025-10-15","kind":"grant","planned":false,"acquired":true,"shares":43650,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the award of restricted stock units (\"RSUs\") pursuant to the Karyopharm Therapeutics Inc. 2022 Equity Incentive Plan, as amended. RSUs convert into Karyopharm Therapeutics Inc. common stock on a one-for-one basis. The RSUs vest 100% on December 31, 2026."}],"balance_after":65075,"source":{"system":"sec-edgar","filing":"0001193125-25-241479","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1837741/000119312525241479/ownership.xml","form_type":"4"}},{"id":1039414,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":46920,"kind":"person","name":"Mano Michael","position":1,"cik":"0001837741","reported_name":"Mano Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, General Counsel&Secretary"}}],"security":"Common Stock","published_at":"2025-09-16T20:34:47.000Z","date":"2025-09-15","kind":"sale","planned":false,"acquired":false,"shares":234,"price":6.43,"value":1504.62,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was effected pursuant to a durable automatic sale instruction plan adopted by the reporting person on May 16, 2022, and represents a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of PSUs. The sale does not represent a discretionary trade by the reporting person."}],"balance_after":21425,"source":{"system":"sec-edgar","filing":"0001193125-25-205049","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1837741/000119312525205049/ownership.xml","form_type":"4"}},{"id":1039413,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":46920,"kind":"person","name":"Mano Michael","position":1,"cik":"0001837741","reported_name":"Mano Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, General Counsel&Secretary"}}],"security":"Common Stock","published_at":"2025-09-16T20:34:47.000Z","date":"2025-09-12","kind":"grant","planned":false,"acquired":true,"shares":612,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of the issuer's common stock underlying performance-based restricted stock units (\"PSUs\") granted in February 2023 that have been earned based on the level of achievement of the clinical milestone for complete enrollment in the Company's Phase 3 SENTRY trial, as certified by the issuer's Compensation Committee on September 12, 2025. Each earned PSU represents the contingent right to receive one share of the issuer's common stock upon vesting. The earned PSUs vested on September 12, 2025."}],"balance_after":21659,"source":{"system":"sec-edgar","filing":"0001193125-25-205049","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1837741/000119312525205049/ownership.xml","form_type":"4"}},{"id":1219777,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":46920,"kind":"person","name":"Mano Michael","position":1,"cik":"0001837741","reported_name":"Mano Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, General Counsel&Secretary"}}],"security":"Common Stock","published_at":"2025-03-06T21:13:53.000Z","date":"2025-03-04","kind":"sale","planned":false,"acquired":false,"shares":2793,"price":6.29,"value":17567.97,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a durable automatic sale instruction plan adopted by the reporting person on May 16, 2022, and represents a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of restricted stock units. The sale does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $6.11 to $6.31, inclusive. The reporting person will provide upon request by the Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":21047,"source":{"system":"sec-edgar","filing":"0000950170-25-034650","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1837741/000095017025034650/ownership.xml","form_type":"4"}},{"id":1229282,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":46920,"kind":"person","name":"Mano Michael","position":1,"cik":"0001837741","reported_name":"Mano Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, General Counsel&Secretary"}}],"security":"Stock Option (right to buy)","published_at":"2025-03-04T21:46:17.000Z","date":"2025-02-28","kind":"grant","planned":false,"acquired":true,"shares":4500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Amounts reported in this Form 4 reflect the one-for-fifteen reverse stock split effected by the Issuer on February 25, 2025."},{"field":"shares","element":"transactionShares","label":"F2","text":"Amounts reported in this Form 4 reflect the one-for-fifteen reverse stock split effected by the Issuer on February 25, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option was granted on February 28, 2025 pursuant to the 2022 Plan. The shares underlying this option vest as to 25% of the shares on February 28, 2026, with the remaining 75% vesting in 36 equal monthly installments thereafter."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"Amounts reported in this Form 4 reflect the one-for-fifteen reverse stock split effected by the Issuer on February 25, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Amounts reported in this Form 4 reflect the one-for-fifteen reverse stock split effected by the Issuer on February 25, 2025."}],"balance_after":4500,"derivative":{"exercise_price":7.95,"expiration_date":"2035-02-27","underlying":"Common Stock","underlying_shares":4500},"source":{"system":"sec-edgar","filing":"0000950170-25-032280","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1837741/000095017025032280/ownership.xml","form_type":"4"}},{"id":1229281,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":46920,"kind":"person","name":"Mano Michael","position":1,"cik":"0001837741","reported_name":"Mano Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, General Counsel&Secretary"}}],"security":"Stock Option (right to buy)","published_at":"2025-03-04T21:46:17.000Z","date":"2025-02-28","kind":"grant","planned":false,"acquired":true,"shares":6666,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Amounts reported in this Form 4 reflect the one-for-fifteen reverse stock split effected by the Issuer on February 25, 2025."},{"field":"shares","element":"transactionShares","label":"F2","text":"Amounts reported in this Form 4 reflect the one-for-fifteen reverse stock split effected by the Issuer on February 25, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option was granted on February 28, 2025 pursuant to the 2022 Plan. The shares underlying this option vest as to 25% of the shares on February 28, 2026, with the remaining 75% vesting in 36 equal monthly installments thereafter."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"Amounts reported in this Form 4 reflect the one-for-fifteen reverse stock split effected by the Issuer on February 25, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Amounts reported in this Form 4 reflect the one-for-fifteen reverse stock split effected by the Issuer on February 25, 2025."}],"balance_after":6666,"derivative":{"exercise_price":7.95,"expiration_date":"2035-02-27","underlying":"Common Stock","underlying_shares":6666},"source":{"system":"sec-edgar","filing":"0000950170-25-032280","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1837741/000095017025032280/ownership.xml","form_type":"4"}},{"id":1229280,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":46920,"kind":"person","name":"Mano Michael","position":1,"cik":"0001837741","reported_name":"Mano Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, General Counsel&Secretary"}}],"security":"Common Stock","published_at":"2025-03-04T21:46:17.000Z","date":"2025-02-28","kind":"grant","planned":false,"acquired":true,"shares":2250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Amounts reported in this Form 4 reflect the one-for-fifteen reverse stock split effected by the Issuer on February 25, 2025."},{"field":"shares","element":"transactionShares","label":"F3","text":"Represents the award of RSUs pursuant to the 2022 Plan. RSUs convert into Karyopharm Therapeutics Inc. common stock on a one-for-one basis. The RSUs vest in two equal annual installments beginning February 28, 2026."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Amounts reported in this Form 4 reflect the one-for-fifteen reverse stock split effected by the Issuer on February 25, 2025."}],"balance_after":23840,"source":{"system":"sec-edgar","filing":"0000950170-25-032280","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1837741/000095017025032280/ownership.xml","form_type":"4"}},{"id":1229279,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":46920,"kind":"person","name":"Mano Michael","position":1,"cik":"0001837741","reported_name":"Mano Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, General Counsel&Secretary"}}],"security":"Common Stock","published_at":"2025-03-04T21:46:17.000Z","date":"2025-02-28","kind":"grant","planned":false,"acquired":true,"shares":3333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the award of restricted stock units (\"RSUs\") pursuant to the Karyopharm Therapeutics Inc. 2022 Equity Incentive Plan, as amended (the \"2022 Plan\"). RSUs convert into Karyopharm Therapeutics Inc. common stock on a one-for-one basis. The RSUs vest in three equal annual installments beginning February 28, 2026."},{"field":"shares","element":"transactionShares","label":"F2","text":"Amounts reported in this Form 4 reflect the one-for-fifteen reverse stock split effected by the Issuer on February 25, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Amounts reported in this Form 4 reflect the one-for-fifteen reverse stock split effected by the Issuer on February 25, 2025."}],"balance_after":21590,"source":{"system":"sec-edgar","filing":"0000950170-25-032280","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1837741/000095017025032280/ownership.xml","form_type":"4"}},{"id":1414087,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":46920,"kind":"person","name":"Mano Michael","position":1,"cik":"0001837741","reported_name":"Mano Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, General Counsel&Secretary"}}],"security":"Common Stock","published_at":"2024-09-05T20:28:14.000Z","date":"2024-09-04","kind":"sale","planned":false,"acquired":false,"shares":3971,"price":0.7218,"value":2866.2678,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a durable automatic sale instruction plan adopted by the reporting person on May 16, 2022, and represents a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of restricted stock units. The sale does not represent a discretionary trade by the reporting person."}],"balance_after":273881,"source":{"system":"sec-edgar","filing":"0000950170-24-104038","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1837741/000095017024104038/ownership.xml","form_type":"4"}},{"id":1603486,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":46920,"kind":"person","name":"Mano Michael","position":1,"cik":"0001837741","reported_name":"Mano Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, General Counsel&Secretary"}}],"security":"Common","published_at":"2024-03-05T00:38:37.000Z","date":"2024-03-01","kind":"sale","planned":false,"acquired":false,"shares":3576,"price":1.2,"value":4291.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"This transaction was effected pursuant to a durable automatic sale instruction plan adopted by the reporting person on May 16, 2022, and represents a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of performance-based restricted stock units. The sale does not represent a discretionary trade by the reporting person."}],"balance_after":277852,"source":{"system":"sec-edgar","filing":"0000950170-24-025190","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1837741/000095017024025190/ownership.xml","form_type":"4"}},{"id":1603485,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":46920,"kind":"person","name":"Mano Michael","position":1,"cik":"0001837741","reported_name":"Mano Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, General Counsel&Secretary"}}],"security":"Common","published_at":"2024-03-05T00:38:37.000Z","date":"2024-02-29","kind":"sale","planned":false,"acquired":false,"shares":16973,"price":1.17,"value":19858.41,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a durable automatic sale instruction plan adopted by the reporting person on May 16, 2022, and represents a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of restricted stock units. The sale does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $1.12 to $1.18, inclusive. The reporting person will provide upon request by the Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":281428,"source":{"system":"sec-edgar","filing":"0000950170-24-025190","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1837741/000095017024025190/ownership.xml","form_type":"4"}},{"id":1610196,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":46920,"kind":"person","name":"Mano Michael","position":1,"cik":"0001837741","reported_name":"Mano Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, General Counsel&Secretary"}}],"security":"Common Stock","published_at":"2024-02-29T22:35:46.000Z","date":"2024-02-28","kind":"grant","planned":false,"acquired":true,"shares":147000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the award of restricted stock units (\"RSUs\") pursuant to the Karyopharm Therapeutics Inc. 2022 Equity Incentive Plan, as amended. RSUs convert into Karyopharm Therapeutics Inc. common stock on a one-for-one basis. The RSUs vest in three equal annual installments beginning February 28, 2025."}],"balance_after":298401,"source":{"system":"sec-edgar","filing":"0000950170-24-023290","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1837741/000095017024023290/ownership.xml","form_type":"4"}},{"id":1671051,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":46920,"kind":"person","name":"Mano Michael","position":1,"cik":"0001837741","reported_name":"Mano Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, General Counsel&Secretary"}}],"security":"Common Stock","published_at":"2024-01-25T23:53:53.000Z","date":"2024-01-24","kind":"grant","planned":false,"acquired":true,"shares":9167,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of the issuer's common stock underlying performance-based restricted stock units (\"PSUs\") granted in February 2023 that have been earned based on the level of achievement of a certain clinical milestone, as certified by the issuer's compensation committee on January 24, 2024. Each earned PSU represents the contingent right to receive one share of the issuer's common stock upon vesting. The earned PSUs will vest on February 28, 2024, the first anniversary of the grant date, subject to continued employment through such vesting date."}],"balance_after":151401,"source":{"system":"sec-edgar","filing":"0000950170-24-007589","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1837741/000095017024007589/ownership.xml","form_type":"4"}},{"id":1789379,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":46920,"kind":"person","name":"Mano Michael","position":1,"cik":"0001837741","reported_name":"Mano Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, General Counsel&Secretary"}}],"security":"Common Stock","published_at":"2023-09-05T20:29:08.000Z","date":"2023-09-01","kind":"sale","planned":false,"acquired":false,"shares":3888,"price":1.3313,"value":5176.0944,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a durable automatic sale instruction plan adopted by the reporting person on May 16, 2022, and represents a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of restricted stock units.  The sale does not represent a discretionary trade by the reporting person."}],"balance_after":142234,"source":{"system":"sec-edgar","filing":"0001209191-23-048161","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1837741/000120919123048161/doc4.xml","form_type":"4"}},{"id":1979936,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":46920,"kind":"person","name":"Mano Michael","position":1,"cik":"0001837741","reported_name":"Mano Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, General Counsel&Secretary"}}],"security":"Common Stock","published_at":"2023-03-02T22:35:19.000Z","date":"2023-03-01","kind":"sale","acquired":false,"shares":6878,"price":3.0292,"value":20834.8376,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of restricted stock units and does not represent a discretionary trade by the reporting person."}],"balance_after":146122,"source":{"system":"sec-edgar","filing":"0001209191-23-014865","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1837741/000120919123014865/doc4.xml","form_type":"4"}},{"id":1979935,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":46920,"kind":"person","name":"Mano Michael","position":1,"cik":"0001837741","reported_name":"Mano Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, General Counsel&Secretary"}}],"security":"Common Stock","published_at":"2023-03-02T22:35:19.000Z","date":"2023-02-28","kind":"grant","acquired":true,"shares":70000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the award of restricted stock units (\"RSUs\") pursuant to the Karyopharm Therapeutics Inc. 2022 Equity Incentive Plan. RSUs convert into Karyopharm Therapeutics Inc. common stock on a one-for-one basis. The RSUs vest in three equal annual installments beginning February 28, 2024."}],"balance_after":153000,"source":{"system":"sec-edgar","filing":"0001209191-23-014865","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1837741/000120919123014865/doc4.xml","form_type":"4"}},{"id":2169091,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":46920,"kind":"person","name":"Mano Michael","position":1,"cik":"0001837741","reported_name":"Mano Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, General Counsel&Secretary"}}],"security":"Stock Option (right to buy)","published_at":"2022-09-02T01:01:40.000Z","date":"2022-08-31","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was granted on August 31, 2022 pursuant to the Plan.  The shares underlying this option vest as to 50% of the shares on August 31, 2023, with the remaining 50% vesting on August 31, 2024."}],"balance_after":30000,"derivative":{"exercise_price":5.06,"expiration_date":"2032-08-30","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001209191-22-048396","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1837741/000120919122048396/doc4.xml","form_type":"4"}},{"id":2169090,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":46920,"kind":"person","name":"Mano Michael","position":1,"cik":"0001837741","reported_name":"Mano Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, General Counsel&Secretary"}}],"security":"Common Stock","published_at":"2022-09-02T01:01:40.000Z","date":"2022-08-31","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the award of restricted stock units (\"RSUs\") pursuant to the Karyopharm Therapeutics Inc. 2022 Equity Incentive Plan (the \"Plan\").  RSUs convert into Karyopharm Therapeutics Inc. common stock on a one-for-one basis.  The RSUs vest  as to 50% of the shares on August 31, 2023, with the remaining 50% vesting on August 31, 2024."}],"balance_after":83000,"source":{"system":"sec-edgar","filing":"0001209191-22-048396","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1837741/000120919122048396/doc4.xml","form_type":"4"}},{"id":2361277,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":46920,"kind":"person","name":"Mano Michael","position":1,"cik":"0001837741","reported_name":"Mano Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, General Counsel&Secretary"}}],"security":"Stock Option (right to buy)","published_at":"2022-03-02T20:14:14.000Z","date":"2022-02-28","kind":"grant","acquired":true,"shares":81000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was granted on February 28, 2022 pursuant to the Plan.  The shares underlying this option vest as to 25% of the shares on February 28, 2023, with the remaining 75% vesting in 36 equal monthly installments thereafter."}],"balance_after":81000,"derivative":{"exercise_price":10.33,"expiration_date":"2032-02-27","underlying":"Common Stock","underlying_shares":81000},"source":{"system":"sec-edgar","filing":"0001209191-22-014621","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1837741/000120919122014621/doc4.xml","form_type":"4"}},{"id":2361276,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":46920,"kind":"person","name":"Mano Michael","position":1,"cik":"0001837741","reported_name":"Mano Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, General Counsel&Secretary"}}],"security":"Common Stock","published_at":"2022-03-02T20:14:14.000Z","date":"2022-02-28","kind":"grant","acquired":true,"shares":63000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the award of restricted stock units (\"RSUs\") pursuant to the Karyopharm Therapeutics Inc. 2013 Stock Incentive Plan (the \"Plan\").  RSUs convert into Karyopharm Therapeutics Inc. common stock on a one-for-one basis.  The RSUs vest in four equal annual installments beginning February 28, 2023."}],"balance_after":63000,"source":{"system":"sec-edgar","filing":"0001209191-22-014621","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1837741/000120919122014621/doc4.xml","form_type":"4"}}]}